Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Dec 15, 2023

    HBM 9033 Out-license to Pfizer

  2. Aug 29, 2023

    2023 Interim Results Online Conference

  3. Mar 29, 2023

    2022 Annual Results Online Conference

  4. Dec 12, 2022

    2022 Investor Day

  5. Aug 31, 2022

    2022 Interim Results Online Conference